JRC Publications Repository

JRC Publications Repository >

Browsing by Author DE VOS F.

Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 4 of 4
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2005Alpha-Immunotherapy with 213Bi-Rituximab Compared to External Gamma Irradiation, Immunotherapy and Chemotherapy in B-CLL in vitro: Correlation with Clinical Chemotherapy Sensitivity.OFFNER Fritz; VANDENBULCKE Katja; DE VOS F.; JANSSENS A.; APOSTOLIDIS Christos; JANSSENS Willem; NIKULA T.k.; THIERENS H.; BRANS B.; DIERCKX R., et alArticles in Journals
2004Importance of Receptor Density in Alpha Radioimmunotherapy in B Cell Malignancies: an In-vitro Study.VANDENBULCKE Katja; THIERENS H.; OFFNER Fritz; JANSSENS A.; DE GELDER V.; BACHER K.; PHILIPPE Jan; DE VOS F.; DIERCKX R.; APOSTOLIDIS Christos, et alArticles in Journals
2003In Vitro Evaluation of 231Bi-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.VANDENBULCKE K.; DE VOS F.; OFFNER Fritz; PHILIPPE Jan; APOSTOLIDIS Christos; MOLINET Roger; NIKULA T.k.; BACHER K.; DE GELDER V.; VRAL A., et alArticles in Journals
2005In Vitro Evaluation of High-LET 213Bi-Therapy Combined to Other Therapeutic Agents for the Treatment of B-CLL.VANDENBULCKE Katja; THIERENS H.; DE VOS F.; PHILIPPE Jan; OFFNER Fritz; APOSTOLIDIS Christos; MORGENSTERN A.; BACHER K.; DE GELDER V.; DIERCKX R., et alArticles in Journals
Showing results 1 to 4 of 4

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top